Short Interest in BioVie Inc. (NASDAQ:BIVI) Drops By 44.0%

BioVie Inc. (NASDAQ:BIVI) was the recipient of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, a drop of 44.0% from the December 15th total of 2,090,000 shares. Based on an average daily trading volume, of 6,120,000 shares, the days-to-cover ratio is presently 0.2 days.

BioVie Trading Down 1.4 %

Shares of NASDAQ BIVI traded down $0.03 during midday trading on Tuesday, reaching $2.07. 68,692 shares of the company were exchanged, compared to its average volume of 1,283,313. The stock has a market cap of $36.78 million, a P/E ratio of -0.18 and a beta of 0.49. BioVie has a 1 year low of $1.04 and a 1 year high of $33.10. The stock has a fifty day simple moving average of $2.63 and a 200 day simple moving average of $2.07.

BioVie Company Profile

BioVie Inc, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease.